Investor Signup
HIP’s strategic value comes from its investor network—bringing together institutional and non-institutional investors to collaborate, conduct diligence, and share decisions on leading healthcare innovations.
Click here to view the members of our investor community
Our goals for the investor network are simple
Save you time
We do a lot of the early work to make sure that the time you spend with us is valuable by exposing you to a number of opportunities in a short amount of time, without dealing with overwhelming solicitation by start-ups.
Bring you pre-screened companies
Our subject matter experts and clinical advisors conduct thorough audits and we prep all the entrepreneurs to ensure that they are able to articulate their value proposition in a concise and direct manner.
Connect you with other investors
Opportunity to network with like-minded investors and advisors in a comfortable environment provides an opportunity to hear varied experts opinions on the start-ups adding to your due diligence process.
What you can expect before, during and after the meeting
Before
Get access to pre-screened startups attending investor meetings through the HIP Investor Platform, including detailed and relevant information.
During
Join investor meetings with like-minded healthcare investors. After each startup presentation, contribute your expertise through the Q&A and confidential diligence discussions.
After
Results of investor meetings are managed on the HIP Investor Platform, giving you access to diligence reports, relevant data room content, and real-time insights into each investment opportunity.
How to get started
Step 1
Sign up below to join our investor network
Step 2
Connect with HIP leadership to learn more about the HIP approach. Get onboarded to the HIP Investor Platform and gain access to the schedule of investor meetings
Step 3
Join investor meetings in person, virtually, or through the HIP Investor Platform—and get involved!
Frequently asked questions
HIP is an opportunistic, healthcare-only venture capital firm built with and for a community of seasoned non-institutional investors (angels, family offices, physicians) and institutional investors (VCs, health systems, strategics). We screen and invite startups to begin their investment process by presenting at one of our Investor Meetings. Check out the About Us to learn more about HIP.
After completing the sign-up form and verifying that you are an accredited investor, we conduct introduction and vetting calls to validate your thesis, approach, and interest in being part of a multidisciplinary collective of like-minded healthcare investors.
HIP offers a unique opportunity to see pre-selected healthcare startups that undergo an extensive collaborative diligence process aligned with your investment criteria, while also providing the chance to network with other investors and healthcare experts.
We host 12–15 meetings each year (Spring Series, Summer Off-Cycle, Fall Series). All meetings are held on Zoom, with select sessions also hosted in person in Silicon Valley and other HIP investor cities.
With deep roots in the healthcare space, our network spans the globe. The majority of our startup deal flow (~85%) comes through the HIP investor network, accelerators, and professional associations.
We are purely focused on the healthcare space. Our typical focus is digital health (consumer and provider/payer), healthcare IT, medical device, and life science. We will not look at drug discovery and large scale bioscience technology at this time.
Once a startup completes the application process, we initiate a thorough screening process that includes:
a) Analysis of product-market fit
b) Review of business and revenue models
c) Subject matter and clinical KOL screening with selected investor network members
Based on these results, we extend invitations for startups to attend an upcoming investor meeting. After performing real-time initial diligence at the meeting, we share the results with the startup and the investor network through the Investor Platform to determine whether to continue the diligence process.
The HIP meeting is targeted towards companies that are between Seed and Series A that have an MVP, and have some level of traction (i.e. revenue, defined business model).
The HIP investor network includes early-stage healthcare venture capital firms, physician investors, angel investors, strategics (health systems, payors) and high net worth individuals.
Absolutely. We foster relationships and networking opportunities among our HIPsters (HIP investors), which is one of our primary goals. A private directory within the Investor Platform helps facilitate engagement as well.
We like to conduct the initial outreach with the companies when presenting your interest. Once that is initiated, investors are free to communicate with the companies while notifying us of their intentions.
Our investors remain confidential and anonymous to the companies until the time of the meeting. We also do not allow companies to contact you before or after the meeting unless we receive your approval to do so.
We ask our investors and advisors to provide real-time feedback on each of the companies presenting, regardless of their interest level in the company. We also share full investment decks, the Zoom recording, and as needed contact information of the presenting companies.
Absolutely. We highly encourage our investors and advisors to be active contributors on the collaborative diligence process that is the thesis of HIP.
Yes! The HIP Investor Platform is accessible only to verified HIP investors. It serves as the central hub for all pre-, during-, and post-meeting information, access to HIP portfolio companies and their data rooms, and the HIPsters directory for investor contacts. All diligence performed on any company is captured here in the form of recordings, documents, and diligence discussions.
Absolutely. HIP has grown significantly through introductions to accredited investors by current HIPsters. We carefully vet each prospective investor to ensure they understand and appreciate the spirit and thesis of the HIP model and process.
Yes please! And we encourage it. A large majority of our deal flow comes to HIP through its investors bringing the opportunities to our table.